Overview of Singular Health's recent announcement

Singular Health Group Ltd (ASX: $SHG) has successfully completed a capital raising, generating $4,123,142 from institutional, sophisticated, and professional investors through the issuance of 37,483,101 fully paid ordinary shares at $0.11 per share. Additionally, the company has issued 766,267 shares on the conversion of SHGOPT09 unlisted options at $0.10 each, raising a further $76,626.70, and 338,877 shares under its employee incentive plan.

Executive commentary on capital raising and future plans

The funds raised will be utilized to accelerate our United States commercialization efforts and capitalize on the recent sales traction in the United States. We are committed to updating our investors on the progress and conversion of current opportunities into sales. Furthermore, we will continue to seek additional investment opportunities to strengthen our balance sheet as part of our commercialization strategy. A portion of the raised funds will also be allocated to advance the development of an initial Medical Artificial Intelligence (AI)-in-the-Cloud system.

Summary of Singular Health's capital raising and future outlook

Singular Health Group Ltd (ASX: $SHG) has successfully completed a capital raising, securing funds to expedite its United States commercialization efforts and further develop a Medical Artificial Intelligence (AI)-in-the-Cloud system. The company remains focused on updating investors on its progress and sales conversions while actively seeking additional investment opportunities to bolster its balance sheet. Singular Health's commitment to leveraging advanced technologies to develop patient-specific solutions underscores its dedication to innovation and growth.